Aon projects 9.70% APAC medical cost growth for 2027: stock pre-market at EUR 245.05

Aon stock was at EUR 245.05 pre-market at Lang & Schwarz on October 12, 2026, at 7:51 a.m. CEST. The company released its 2027 medical trend report.

Aon released its 2027 Global Medical Trend Rates Report on October 12, 2026, projecting that medical costs in Asia Pacific will increase by 9.70% in 2027, compared with 11.30% in 2026. Aon stock was at EUR 245.05 pre-market at Lang & Schwarz at 7:51 a.m. CEST. The release identifies Aon plc as the issuer and lists the company under NYSE ticker AON. Markets Insider reported the EQS-distributed announcement.

Pre-market indication

The Lang & Schwarz indication was EUR 245.05 on October 12, 2026, at 7:51 a.m. CEST. The bid was EUR 244.40 and the ask was EUR 245.70. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Aon plc stock.

What matters today

Aon has scheduled the release of its third-quarter 2026 results for October 28, 2026, according to its newsroom. The company’s APAC medical trend projection is 9.70% for 2027, compared with 11.30% for 2026. Aon’s global medical trend projection is 9.00% for 2027, down from 9.80% for 2026. Aon’s media releases list the earnings date and the company’s recent announcements.

Medical trend in the report refers to the anticipated annual percentage increase in the cost of treating patients and providing healthcare services. Aon said cardiovascular disease, ENT and lung disorders, and cancer or tumor growth remain leading drivers of medical claims in the region. The report is based on insights from more than 100 Aon offices that broker, administer or advise on employer-sponsored medical plans. The report details also identify wellness initiatives, plan design changes, and cost containment strategies as measures employers are expected to use.

Market context: Market report S&P 500.

More news and analysis on Aon plc stock